Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer
Geburtshilfe und Frauenheilkunde · 01.03.2023 · 83 (03) · 289-298
DOI: 10.1055/a-2018-9053 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.03.2023. Verfasst von Tanja N Fehm und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The treatment of patients with early stage breast cancer has changed in recent years due to the introduction of pembrolizumab, olaparib, and abemaciclib. These and other drugs with the same class of active ingredient are currently in trial for various indications. This review article summarizes the latest results that have either been presented at major conferences such as the ESMO 2022 or published recently in international journals. This includes reports on newly discovered breast cancer genes, atezolizumab in neoadjuvant therapy in HER2-positive patients, long-term data from the APHINITY study, and on how preoperative peritumoral application of local anesthetics can influence the prognosis. We also present solid data on dynamic Ki-67 from the ADAPT studies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
- Onkologie Aschaffenburg, Aschaffenburg, Germany.
- Department of Gynecology, Hamburg-Eppendorf University Medical Center, Hamburg, Germany.
- Immanuel Hospital Märkische Schweiz, Buckow; Medical University of Brandenburg Theodor-Fontane, Brandenburg, Germany.
- Gynäkologie und Geburtshilfe, Diakonissen-Stiftungs-Krankenhaus Speyer, Speyer, Germany.
- Erlangen University Hospital, Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany.
Zitieren
APA
Fehm, T. N., Welslau, M., Müller, V., Lüftner, D., Schütz, F., Fasching, P. A., Janni, W., Thomssen, C., Witzel, I., Beierlein, M., Belleville, E., Untch, M., Thill, M., Tesch, H., Ditsch, N., Lux, M. P., Aktas, B., Banys-Paluchowski, M., Kolberg-Liedtke, C., …, & Stickeler, E. (2023). Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde, 83(03), 289-298. https://doi.org/10.1055/a-2018-9053
Vancouver
Fehm TN, Welslau M, Müller V, Lüftner D, Schütz F, Fasching PA, et al. Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer. Geburtshilfe und Frauenheilkunde. 2023;83(03):289-298. doi:10.1055/a-2018-9053
BibTeX
@article{Fehm2023,
author = {Fehm, Tanja N and Welslau, Manfred and Müller, Volkmar and Lüftner, Diana and Schütz, Florian and Fasching, Peter A and Janni, Wolfgang and Thomssen, Christoph and Witzel, Isabell and Beierlein, Milena and Belleville, Erik and Untch, Michael and Thill, Marc and Tesch, Hans and Ditsch, Nina and Lux, Michael P and Aktas, Bahriye and Banys-Paluchowski, Maggie and Kolberg-Liedtke, Cornelia and Hartkopf, Andreas D and Wöckel, Achim and Kolberg, Hans-Christian and Harbeck, Nadia and Stickeler, Elmar},
title = {Update Breast Cancer 2022 Part 5 – Early Stage Breast Cancer},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2023},
volume = {83},
number = {03},
pages = {289--298},
doi = {10.1055/a-2018-9053}
}
EUVIMED